Background : Myelodysplastic syndrome (MDS) is a group of disorders involving he-mopoietic dysfunction leading to leukemia. Although recently progress has been
Programmed cell death protein 1 (PD- 1) /programmed cell death ligand 1 (PD- L1) blockade is an important therapeutic strategy for melanoma, despite its low cli